Cipla Gets Ventolin Boost, But Brokerages Are Split On Execution Risks — Check Revised Targets

Morgan Stanley has retained its Underweight rating, while nudging up the target price to Rs 1,237 from Rs 1,211. In contrast, Citi continues to back the stock with a Buy rating and a higher target price of Rs 1,530.